1[1]Chamless L,Keil U,Dobson A,et al.Population versus clinical view of case fatality from acute coronary heart disease:results from the WHO MONICA Project 1985-1990[J].Circulation,1997,96:3849-3859.
2[2]Bayes de Luna A,Coumel P,Leclerq JF.Ambulatory sudden cardiac death:mechanisms of production of fatal arrhythmia on the basis of data from 157 cases[J].Am Heart J,1989,117:151-159.
3[3]Cobb LA,Fahrenbruch CE,Olsufka M,et al.Changing incidence of out of hospital ventricular fibrillation[J].1980-2000.JAMA,2002,288:3008-3013.
4[4]Wenzel V,krismer AC,Arntz HR,et al.A comparison of vasopressin and epinephrine for out of hospital cardiopulmonary resuscitation[J].N Engl J Med,2004,350:105-113.
5[5]Iseri LT,Siner EJ,Humphrey SB,et al.Prehospital cardiac arrest after arrival of the paramedic unit[J].JACEP,1977,6:530-535.
6[6]Paradis NA,Martin GB,River EP,et al.Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation[J].JAMA,1990,263:1106-1113.
7[7]Fox AW,May RE,Mitch WE.Comparison of peptide and nonpeptide receptor-mediated responses in rat tail artery[J].J Cardiovasc Pharmacol,1992,20:282-289.
8[8]Lindner KH,Strohemnger HU,Ensinger H,Hetzel WD,Ahnefeld FW,Geogieff M.stress hormone response during and after cardiopulmonary resuscitation[J].Anesthesiology,1992,77:662-668.
9[9]DC Morris,BE Dereczyk,M Grzybowski,et al.Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation[J].Academ Emerg Med,2002 4:878-883.
10[10]Praadis NA,Wenzel V,Southall J.Pressor drugs in the treatment of cardiac arrest[J].Cardiol Clin,2002,20:61 -78.
同被引文献9
1Barrett LK,Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock[J].Crit Care Med, 2007, 35 (1): 33-40.
2Gordon AC, W ang N , W alley KR, et al. The cardiopulmonary effects of vasopressin compared with norepinephrinc in septic shock[J].Chest, 2012, 142(3) : 593-605.
3Meyer S, Gortner L, M cGuirc W,et al. Vasoprcssin in shock in children[J]..Anaesthesia, 2008, 63 (3) 228-234.
4Russel J A, Walley K R, Singer J,et al. Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock[J].the New England Journal of Medicine, 2008,358(9) : 877-887.
5Mitchell M. Levy, MD; Mitchell P, et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003, 31 (4): 1250-1256.
6Phillinger RD, Carlet JM, Maswr H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].. Crit Care Med, 2004,32(3) : 858-872.
7Martin G S, Eaton S, Mealer M, eta 1. Extravascular lung water in patients with severe sepsis: a prospective cohort study[J].. Crit Care, 2005, 9(2): 136-137.
8Russell JA, Walley KR. Vasopressin and its immune effects in septic shock[J]. J innate Immun,2010,2(5):446-460.
9Scott LV, Dinah TG: Vasopressin and the regulation of hypothalamic- pituitary-adrenal axis function: Implications for the pathophysiology of deoression[J1..Lffe Sci 1998,62:1985-1998.
